Vancouver firm's AI platform will generate chemical compounds based on Merck’s therapeutic targets. A Vancouver startup using artificial intelligence (AI) to discover new drugs has struck a deal with ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research ...
Variational powers Omni, a platform that allows users to trade perpetual futures on hundreds of markets with zero fees. Variational, a protocol for peer-to-peer derivatives trading on Arbitrum, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results